In an experimental model of acute MI in T2D rats, empagliflozin normalized the size and number of heart mitochondria and prevent the diabetes-induced excessive reduction in mitochondrial size through inhibition of Fis1 upregulation and consequent ROS production [112]. The gene discussed is FIS1; the disease is type 2 diabetes mellitus.